Search research articles
Contact Us
Filters
Showing results (61-70 of 115) with videos related to
Page
of 12
Sort By:
Cancer Research
|
August 1, 1990
Inhibition of cancer cell urokinase plasminogen activator by its specific inhibitor PAI-2 and subsequent effects on extracellular matrix degradation
M S Baker, P Bleakley, G C Woodrow, et al.
Medical Care
|
January 1, 1991
Estimating the treatment costs of breast and lung cancer
M S Baker, L G Kessler, N Urban, et al.
Molecular Human Reproduction
|
March 24, 1998
Gene expression of plasminogen activation cascade components in human term gestational tissues with labour onset
D Tsatas, M S Baker, E K Moses, et al.
American Journal of Surgery
|
May 1, 1977
Sump tube drainage as a source of bacterial contamination
M S Baker, K A Borchardt, B H Baker, et al.
Free Radical Biology & Medicine
|
January 1, 1991
The oxidant hypochlorite (OCl-), a product of the myeloperoxidase system, degrades articular cartilage proteoglycan aggregate
M Katrantzis, M S Baker, C J Handley, et al.
The Journal of Surgical Research
|
May 9, 2001
Expression of a dominant negative inhibitor of NF-kappaB protects MIN6 beta-cells from cytokine-induced apoptosis
M S Baker, X Chen, X C Cao, et al.
Cancer Metastasis Reviews
|
September 5, 2015
Integrin αvβ6 sets the stage for colorectal cancer metastasis
D I Cantor, H R Cheruku, E C Nice, et al.
Infection and Immunity
|
October 1, 1996
Clusterin, a putative complement regulator, binds to the cell surface of Staphylococcus aureus clinical isolates
S R Partridge, M S Baker, M J Walker, et al.
Journal of Cellular Physiology
|
January 7, 2000
Evidence for intracellular cleavage of plasminogen activator inhibitor type 2 (PAI-2) in normal epidermal keratinocytes
B C Risse, N M Chung, M S Baker, et al.
The Journal of Clinical Investigation
|
July 1, 1996
Evidence of oxidant-induced injury to epithelial cells during inflammatory bowel disease
S J McKenzie, M S Baker, G D Buffinton, et al.
Page
of 12
Search research articles
Search
Showing results (61-70 of 115) with videos related to
Sort By:
Page
of 12
Cancer Research
|
August 1, 1990
Inhibition of cancer cell urokinase plasminogen activator by its specific inhibitor PAI-2 and subsequent effects on extracellular matrix degradation
M S Baker, P Bleakley, G C Woodrow, et al.
Medical Care
|
January 1, 1991
Estimating the treatment costs of breast and lung cancer
M S Baker, L G Kessler, N Urban, et al.
Molecular Human Reproduction
|
March 24, 1998
Gene expression of plasminogen activation cascade components in human term gestational tissues with labour onset
D Tsatas, M S Baker, E K Moses, et al.
American Journal of Surgery
|
May 1, 1977
Sump tube drainage as a source of bacterial contamination
M S Baker, K A Borchardt, B H Baker, et al.
Free Radical Biology & Medicine
|
January 1, 1991
The oxidant hypochlorite (OCl-), a product of the myeloperoxidase system, degrades articular cartilage proteoglycan aggregate
M Katrantzis, M S Baker, C J Handley, et al.
The Journal of Surgical Research
|
May 9, 2001
Expression of a dominant negative inhibitor of NF-kappaB protects MIN6 beta-cells from cytokine-induced apoptosis
M S Baker, X Chen, X C Cao, et al.
Cancer Metastasis Reviews
|
September 5, 2015
Integrin αvβ6 sets the stage for colorectal cancer metastasis
D I Cantor, H R Cheruku, E C Nice, et al.
Infection and Immunity
|
October 1, 1996
Clusterin, a putative complement regulator, binds to the cell surface of Staphylococcus aureus clinical isolates
S R Partridge, M S Baker, M J Walker, et al.
Journal of Cellular Physiology
|
January 7, 2000
Evidence for intracellular cleavage of plasminogen activator inhibitor type 2 (PAI-2) in normal epidermal keratinocytes
B C Risse, N M Chung, M S Baker, et al.
The Journal of Clinical Investigation
|
July 1, 1996
Evidence of oxidant-induced injury to epithelial cells during inflammatory bowel disease
S J McKenzie, M S Baker, G D Buffinton, et al.
Page
of 12